Do cardiovascular mechanisms participate in thermoregulatory activity of alpha 2-adrenoceptor agonists and antagonists in rabbits?
Szreder
Z
Z
Department of Pharmacology, Medical University of Gdansk, Poland.
D058647:Adrenergic alpha-2 Receptor Agonists; D058669:Adrenergic alpha-2 Receptor Antagonists; D000316:Adrenergic alpha-Agonists / Q000494:pharmacology*; D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology*; D000818:Animals; D001381:Azepines / Q000494:pharmacology; D001552:Benzazepines / Q000494:pharmacology; D001831:Body Temperature / Q000187:drug effects; D001833:Body Temperature Regulation / Q000187:drug effects*; D000068438:Brimonidine Tartrate; D003080:Cold Temperature; D004423:Ear; D004734:Energy Metabolism / Q000187:drug effects; D005334:Fever / Q000503:physiopathology; D006439:Hemodynamics / Q000187:drug effects; D008070:Lipopolysaccharides / Q000494:pharmacology; D008297:Male; D011749:Pyrogens / Q000494:pharmacology; D011810:Quinoxalines / Q000494:pharmacology; D011817:Rabbits; D015016:Yohimbine / Q000494:pharmacology
D058647:Adrenergic alpha-2 Receptor Agonists; D058669:Adrenergic alpha-2 Receptor Antagonists; D000316:Adrenergic alpha-Agonists; D000317:Adrenergic alpha-Antagonists; D001381:Azepines; D001552:Benzazepines; D008070:Lipopolysaccharides; D011749:Pyrogens; D011810:Quinoxalines; C054935:SK&F 104078; C071739:SK&F 104856; D015016:Yohimbine; D000068438:Brimonidine Tartrate; C024763:talipexole